WGSGeneDx Holdings Corp.

Nasdaq sema4.com


$ 19.42 $ -0.60 (-3 %)    

Wednesday, 08-May-2024 14:24:09 EDT
QQQ $ 439.90 $ 1.67 (0.38 %)
DIA $ 390.20 $ 1.91 (0.49 %)
SPY $ 517.00 $ 1.74 (0.34 %)
TLT $ 90.32 $ 0.01 (0.01 %)
GLD $ 213.91 $ 0.32 (0.15 %)
$ 19.29
$ 20.02
$ 0.00 x 0
$ 0.00 x 0
$ 19.28 - $ 20.67
$ 1.16 - $ 21.71
347,641
na
502.74M
$ 2.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-29-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-14-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 07-21-2021 06-30-2021 10-Q
13 05-24-2021 03-31-2021 10-Q
14 03-30-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-genedx-hldgs-raises-price-target-to-24

TD Cowen analyst Dan Brennan maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $14 to $24.

 btig-maintains-buy-on-genedx-hldgs-raises-price-target-to-19

BTIG analyst Mark Massaro maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $15 to $19.

 genedx-hldgs-raises-fy2024-sales-guidance-from-220m-230m-to-235m-245m-vs-2261m

GeneDx Hldgs (NASDAQ: WGS) raises FY2024 sales outlook from $220.00 million-230.00 million to $235.00 million-245.00 million.Ge...

 genedx-stock-climbs-after-better-than-expected-q1-results-raises-fy24-guidance

GeneDx reports quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents by 50.75%...

 genedx-hldgs-q1-2024-adj-eps-033-beats-067-estimate-sales-62422m-beat-49463m-estimate

GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.67) b...

 btig-maintains-buy-on-genedx-hldgs-raises-price-target-to-15

BTIG analyst Mark Massaro maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $11 to $15.

 goldman-sachs-maintains-neutral-on-genedx-hldgs-raises-price-target-to-11

Goldman Sachs analyst Matthew Sykes maintains GeneDx Hldgs (NASDAQ:WGS) with a Neutral and raises the price target from $6 t...

 why-science-applications-international-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company r...

 genedx-to-present-data-at-the-2024-american-college-of-medical-genetics-annual-meeting-demonstrating-clinical-superiority-of-its-exome

GeneDx (NASDAQ:WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific c...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION